June 11, 2020

The summer of 2020 – a chance for a positive urban spaces legacy?

Since the UK Government announced funding to promote a ‘once in a generation’ change to the way people travel, it seems all the ‘talk’ has been about pop-up cycleways, wider..

The decline of the U.S dollar is good for asset markets and emerging economies

With the deeply depressed U.S domestic savings now facing intense downward pressure there are serious doubts around the world as to whether the dollar should be the world’s primary reserve..

Babcock International Group resilient business model ready for the year ahead

Babcock International Group plc (LON:BAB) have delivered full year results for the year ended 31 March 2020. Archie Bethel, Babcock Chief Executive, said: “We end a busy year in a..

Just Eat Takeaway.com to combine with Grubhub

Just Eat Takeaway.com (LON:JET) and Grubhub Inc. (NYSE:GRUB) have entered into a definitive agreement whereby the Company is to acquire 100% of the shares of Grubhub in an all-stock transaction..

TalkTalk Telecom Group deliver robust FY20 performance

TalkTalk Telecom Group plc (LON:TALK) have provided preliminary results for the year ended 31 March 2020 (FY20). Headline EBITDA growth of 9.7% (pre-IFRS 16); 34% Fibre customer base growth Strong..

WPP appoints Angela Ahrendts DBE as Non-Executive Director

WPP plc (LON:WPP) has announced the appointment of Angela Ahrendts DBE to its Board as a Non-Executive Director. With a career in fashion and retail spanning more than three decades,..

Reabold Resources ‘shareholders can look forward to an exciting 2020 and beyond’

Reabold Resources plc (LON:RBD), the AIM investing company which focuses on investments in upstream oil and gas projects, has provided its audited results for the year ended 31 December 2019...

Open Orphan signs major contract with a leading vaccine developer

Open Orphan plc (LON:ORPH) a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models, has..

ImmuPharma two specialist US healthcare investments of up to $6.30 million

ImmuPharma plc (LON:IMM – Euronext Growth: ALIMM), the specialist drug discovery and development company, has said that it has entered into agreements with two specialist US healthcare investors for a..

Search

Funds

June 11, 2020

Search

Funds

June 11, 2020

FTSE 100

Funds